Minimally Invasive Treatments of the Thyroid — MIPA-MITT  

Papillary Thyroid Microcarcinoma Clinical Trial

Official title: Multicenter International Prospective Analysis on Minimally Invasive Treatments of the Thyroid (MIPA- MITT) of of Micropapillary Thyroid Carcinoma

Status Recruiting

Clinical Trial Summary

This is a prospective cohort study to test Minimally Invasive Treatments of the Thyroid (MITT) as potential alternative to surgery in patients with Papillary Thyroid MicroCarcinoma (PTMC)

Clinical Trial Description

Image-guided thermal ablations have been successfully applied in the treatment of several type of tumors, and have been recently proposed as a potential alternative to surgery also in patients with thyroid diseases, and named "Minimally Invasive Treatments of the Thyroid (MITT)". These minimally invasive treatments, compared to surgical treatment have similar efficacy, fewer complications, better quality of life, and better cosmetic outcomes. These procedures allow precise delivery of the heat locally to the lesion, sparing the surrounding thyroid tissue, and thus minimizing the invasiveness of the treatment and the impact on thyroid function. This study aim to establish a prospective registry of the cases of patients treated with MITT for a Papillary Thyroid MicroCarcinoma (PTMC), in order to validate the safety of the procedure and to set the basis for collecting long term results in a large cohort of patients. ;

Related Conditions & MeSH terms

• Papillary Thyroid Microcarcinoma
• Thyroid Diseases

• NCT number: NCT06333587
• Study type: Observational
• Source: European Institute of Oncology
• Contact: Giovanni Mauri
• Phone: +390294372691
• Email: giovanni.mauri@ieo.it
• Status: Recruiting
• Start date: October 10, 2022
• Completion date: December 31, 2035